We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical cosmetic ingredient — not a dietary supplement
Growth Factors (topical) is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Growth Factors (topical) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2008–2023 with a typical study size of 50 participants.
Based on 6 studies · 2 RCTs · 142 total participants
Confidence
LowBy outcome
Growth Factors (topical) has an evidence score of 3/10 — emerging evidence based on 6 indexed studies. 'Regenerative' anti-aging serums built around growth factors and cytokines (from human fibroblast cultures, EGF, or snail/plant sources) applied to the skin. The honest framing: growth factors genuinely stimulate fibroblasts and collagen, and small studies report modest wrinkle/texture improvements — but the evidence is weak. The strongest synthesis (a 33-study review) found three head-to-head RCTs with no significant benefit over control, the human trials are mostly small, open-label, and manufacturer-funded, and these are large proteins that may not penetrate intact skin. Biologically plausible, commercially popular, but only low-grade and partly subjective support. Representative study: PMID 37222303.
The commonly studied dose of Growth Factors (topical) is Topical cosmetic only. Growth-factor serums/creams are applied to clean skin once or twice daily per the product. Formulations and growth-factor sources vary widely and are unstandardized, and penetration of large proteins through intact skin is uncertain. There is no oral or systemic dose. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Practical, evidence-based guides that cover Growth Factors (topical).
Explore: Best supplements for Skin, Hair & Beauty
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Topical Growth Factors / EGF cosmeceuticals
'Regenerative' anti-aging serums built around growth factors and cytokines (from human fibroblast cultures, EGF, or snail/plant sources) applied to the skin. The honest framing: growth factors genuinely stimulate fibroblasts and collagen, and small studies report modest wrinkle/texture improvements — but the evidence is weak. The strongest synthesis (a 33-study review) found three head-to-head RCTs with no significant benefit over control, the human trials are mostly small, open-label, and manufacturer-funded, and these are large proteins that may not penetrate intact skin. Biologically plausible, commercially popular, but only low-grade and partly subjective support.
Biologically plausible (growth factors stimulate fibroblasts/collagen) with some consistent low-grade signal, but the strongest review found three head-to-head RCTs with no significant benefit, human data are mostly small/open-label/manufacturer-funded, and large growth-factor proteins may not penetrate intact skin.
Topical growth-factor cosmeceuticals are 'regenerative' anti-aging serums whose active fraction is a mixture of growth factors and cytokines — commonly secreted by cultured human dermal fibroblasts (conditioned media), or epidermal growth factor (EGF), or growth-factor-rich secretions from snails or plants.
This entry covers topical use. The rationale is real: growth factors (EGF, TGF-beta, VEGF) control cell proliferation and differentiation, and skin wound-healing pathways overlap with those implicated in photoaging, so stimulating fibroblasts to make collagen is plausible. But the evidence is weak.
A double-blind vehicle-controlled trial of a >110-growth-factor fibroblast serum (Mehta et al., 2008; n=60) reported greater wrinkle/fine-line reduction than vehicle, though results were 'significant or trending toward significance' and the study was manufacturer-conducted.
The strongest synthesis — a systematic review of 33 studies (9 RCTs, 24 uncontrolled series; Quinlan et al., 2023) — found only modest, largely subjective improvements (texture median <50%, wrinkles <35%) and, critically, three comparative RCTs with no significant difference between treatments.
Small open-label pilots (Hussain 2008, n=14; Seidel & Moy 2015, n=18) report wrinkle/under-eye improvements but lack controls, and even a vehicle-controlled snail-growth-factor RCT (Lim 2020) saw vehicle improve wrinkles as much as active on the headline endpoint.
The honest caveats: most human data are small, open-label, and industry-funded; EGF and most growth factors are large proteins (~6 kDa+) that penetrate intact skin poorly; and because growth factors promote proliferation and angiogenesis, long-term use over sun-damaged skin raises unresolved (though unproven) theoretical safety questions.
So the honest summary: topical growth factors are mechanistically plausible and commercially popular but supported only by weak, partly subjective, industry-leaning evidence. None of this is a health claim.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
Growth factors and cytokines (EGF, TGF-beta, VEGF) normally drive cell proliferation and matrix synthesis in wound healing. Applied to skin, they are proposed to stimulate dermal fibroblasts to produce collagen and elastin — the rationale for 'regenerative' anti-aging serums.
EGF and most growth factors are large proteins (~6 kDa and up) that do not readily cross the intact stratum corneum, casting doubt on whether topically applied growth factors reach living dermal fibroblasts at active concentrations — a key reason real-world effects are uncertain.
Topical cosmetic only. Growth-factor serums/creams are applied to clean skin once or twice daily per the product. Formulations and growth-factor sources vary widely and are unstandardized, and penetration of large proteins through intact skin is uncertain. There is no oral or systemic dose. This library does not provide an ingestion protocol.
| Form | Type |
|---|---|
| 💊Leave-on growth-factor/EGF serum (unstandardized; weak evidence) | Recommended |
| 💊Better-evidenced anti-aging actives (retinoids, vitamin C) for those wanting stronger support | Alternative |
There is no oral or injectable cosmetic form covered here. Growth-factor products are unstandardized.
Minimum: 12 weeks
Optimal: 24 weeks
Cycling: Not required
Note: Applied to clean skin once or twice daily. As a leave-on cosmetic there is no ingestion or meal-timing consideration.
Growth-factor serums are marketed as 'regenerative' anti-aging actives. They are topical cosmetics, not ingested supplements, and the human evidence for benefit is weak and partly subjective.
Small and open-label studies report reduced fine lines and improved texture, but head-to-head RCTs often show no significant advantage over control.
Most human data are small, uncontrolled, and manufacturer-funded; the best synthesis found three comparative RCTs with no significant difference. Treat marketing claims cautiously.
Large growth-factor proteins may not reach the dermis through intact skin, and because growth factors promote proliferation/angiogenesis, long-term use over sun-damaged skin raises unresolved (unproven) theoretical concerns.
No safety data for topical growth-factor cosmeceuticals in pregnancy; discuss with a clinician and consider better-studied actives.
Use caution — growth factors promote cell proliferation/angiogenesis; avoid over suspicious lesions and consult a dermatologist.
Retinoids and vitamin C have far stronger evidence; growth-factor serums are plausible but weakly supported.
Generally layers with other actives; combining many can irritate sensitive skin. Not a systemic interaction — it is not ingested.
Tip: Discontinue if irritation occurs.
Tip: Theoretical, unproven concern; avoid applying over suspicious/precancerous lesions and have skin changes evaluated.
Timing is flexible for Growth Factors (topical) — consistent daily use matters more than the time of day. Growth-factor serums are leave-on cosmetics with no meal-timing relationship; product formulation and (uncertain) penetration matter more than timing.
Growth Factors (topical) is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are mild local irritation, unknown long-term effects (proliferation/angiogenesis). Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy or sensitivity to the formulation; Caution over lesion-prone or actively cancerous/precancerous skin (growth factors promote proliferation — theoretical concern).